{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:07:15Z","timestamp":1790798835097,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.abb.2020.108698","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T02:10:04Z","timestamp":1606529404000},"page":"108698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":243,"special_numbering":"C","title":["Mitochondrial dysfunction in the development and progression of neurodegenerative diseases"],"prefix":"10.1016","volume":"702","author":[{"given":"Joseph","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mercado-Ayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesica","family":"Mercado-Ayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Na","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3059-1089","authenticated-orcid":false,"given":"Sarah","family":"Halawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Ngaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","article-title":"The role of mitochondria in apoptosis","volume":"41","author":"Jeong","year":"2008","journal-title":"BMB Rep."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1873-3468.12956","article-title":"Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease","volume":"592","author":"Nissanka","year":"2018","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010025","article-title":"PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia","volume":"5","author":"Marmolino","year":"2010","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","article-title":"Signaling by ROS drives inflammasome activation","volume":"40","author":"Martinon","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1073\/pnas.91.4.1309","article-title":"Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis","volume":"91","author":"Virbasius","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bst0280033","article-title":"The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin","volume":"28","author":"Hayes","year":"2000","journal-title":"Biochem. Soc. Trans."},{"issue":"9","key":"10.1016\/j.abb.2020.108698_bib9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0006-2952(02)00897-3","article-title":"Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress","volume":"63","author":"Solis","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2020.108698_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-015-0200-8","article-title":"PGC-1\u03b1 activity in nigral dopamine neurons determines vulnerability to \u03b1-synuclein","volume":"3","author":"Ciron","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.abb.2020.108698_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.200105057","article-title":"VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release","volume":"155","author":"Madesh","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"issue":"2\u20133","key":"10.1016\/j.abb.2020.108698_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tox.2005.12.009","article-title":"Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction","volume":"220","author":"Oliveira","year":"2006","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.abb.2020.108698_bib14","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1074\/jbc.272.6.3346","article-title":"Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase","volume":"272","author":"Halestrap","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1073\/pnas.241655498","article-title":"Cytochrome c release from mitochondria proceeds by a two-step process","volume":"99","author":"Ott","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/cdd.2013.186","article-title":"ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis","volume":"21","author":"Shi","year":"2014","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2011-101356","article-title":"PPAR\u03b3 co-activator-1\u03b1 (PGC-1\u03b1) reduces amyloid-\u03b2 generation through a PPAR\u03b3-dependent mechanism","volume":"25","author":"Katsouri","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"24","key":"10.1016\/j.abb.2020.108698_bib19","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1093\/hmg\/ddx361","article-title":"Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease","volume":"26","author":"Branca","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.abb.2020.108698_bib20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.bbadis.2014.05.025","article-title":"Early alterations in energy metabolism in the hippocampus of APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"1842","author":"Pedr\u00f3s","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2020.108698_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.redox.2017.07.006","article-title":"NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology","volume":"13","author":"Rojo","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-018-0342-6","article-title":"MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease","volume":"10","author":"Pohland","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"issue":"1\u20132","key":"10.1016\/j.abb.2020.108698_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11064-015-1765-0","article-title":"MH84: a novel \u03b3-secretase modulator\/PPAR\u03b3 agonist--improves mitochondrial dysfunction in a cellular model of Alzheimer's disease","volume":"41","author":"Pohland","year":"2016","journal-title":"Neurochem. Res."},{"issue":"43","key":"10.1016\/j.abb.2020.108698_bib24","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1073\/pnas.1606171113","article-title":"PPAR\u03b3-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer's disease model","volume":"113","author":"Katsouri","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0578-9","article-title":"Nrf2 activation through the PI3K\/GSK-3 axis protects neuronal cells from A\u03b2-mediated oxidative and metabolic damage","volume":"12","author":"Sotolongo","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-020-00605-6","article-title":"Correction to: Nrf2 activation through the PI3K\/GSK-3 axis protects neuronal cells from A\u03b2-mediatedoxidative and metabolic damage","volume":"12","author":"Sotolongo","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib27","first-page":"484","article-title":"Possible mechanisms underlying treatment of Alzheimer's disease with Traditional Chinese Medicine: active components, potential targets and synthetic pathways of Bulao Elixir","volume":"40","author":"Ren","year":"2020","journal-title":"J.\u00a0Tradit. Chin. Med."},{"issue":"14","key":"10.1016\/j.abb.2020.108698_bib28","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1111\/j.1742-4658.2009.07094.x","article-title":"Overexpression of Tfam protects mitochondria against beta-amyloid-induced oxidative damage in SH-SY5Y cells","volume":"276","author":"Xu","year":"2009","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/ijms.10035","article-title":"Astrocytes protect neurons from A\u03b21-42 peptide-induced neurotoxicity increasing TFAM and PGC-1 and decreasing PPAR-\u03b3 and SIRT-1","volume":"12","author":"Aguirre-Rueda","year":"2015","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neurobiolaging.2014.09.004","article-title":"Increased Alzheimer's disease-like pathology in the APP\/PS1\u0394E9 mouse model lacking Nrf2 through modulation of autophagy","volume":"36","author":"Joshi","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.abb.2020.108698_bib32","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-\u03b3 coactivator 1\u03b1 regulated \u03b2-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.abb.2020.108698_bib33","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","article-title":"Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease","volume":"93","author":"Peng","year":"2005","journal-title":"J.\u00a0Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.abb.2020.108698_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0169-328X(03)00003-2","article-title":"Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease","volume":"111","author":"Michalski","year":"2003","journal-title":"Brain Res. Mol."},{"key":"10.1016\/j.abb.2020.108698_bib35","first-page":"65","article-title":"PGC-1\u03b1 or FNDC5 is involved in modulating the effects of A\u03b2","volume":"9","author":"Xia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.abb.2020.108698_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.abb.2020.108698_bib37","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J.\u00a0Neurochem."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","article-title":"Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"62","author":"Heikkila","year":"1985","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib40","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mds.10695","article-title":"Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations","volume":"19","author":"M\u00fcft\u00fcoglu","year":"2004","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/emmm.200900006","article-title":"Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function","volume":"1","author":"Morais","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.abb.2020.108698_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-12-69","article-title":"Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease","volume":"12","author":"Clark","year":"2011","journal-title":"BMC Med. Genet."},{"issue":"52","key":"10.1016\/j.abb.2020.108698_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson's disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004756","article-title":"Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells","volume":"4","author":"Gegg","year":"2009","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncb2901","article-title":"Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease","volume":"16","author":"Tufi","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2012.01.022","article-title":"Oxidative stress induces mitochondrial fragmentation in frataxin-deficient cells","volume":"418","author":"Lefevre","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"12","key":"10.1016\/j.abb.2020.108698_bib49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jmg.30.12.982","article-title":"Gametic but not somatic instability of CAG repeat length in Huntington's disease","volume":"30","author":"MacDonald","year":"1993","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.abb.2020.108698_bib50","unstructured":"(!!! INVALID CITATION !!! { })."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.abb.2020.108698_bib53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4161\/auto.7.11.17166","article-title":"TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes","volume":"7","author":"Settembre","year":"2011","journal-title":"Autophagy"},{"issue":"142","key":"10.1016\/j.abb.2020.108698_bib54","doi-asserted-by":"crossref","first-page":"142ra197","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1\u03b1 rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","article-title":"PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease","volume":"45","author":"Chiang","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.abb.2020.108698_bib56","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes","volume":"6","author":"Campuzano","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.abb.2020.108698_bib58","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1093\/hmg\/ddx141","article-title":"Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans","volume":"26","author":"Jasoliya","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.abb.2020.108698_bib59","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"13","key":"10.1016\/j.abb.2020.108698_bib60","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/hmg\/ddp183","article-title":"Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia","volume":"18","author":"Coppola","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.abb.2020.108698_bib61","doi-asserted-by":"crossref","first-page":"101520","DOI":"10.1016\/j.redox.2020.101520","article-title":"Frataxin-deficient cardiomyocytes present an altered thiol-redox state which targets actin and pyruvate dehydrogenase","volume":"32","author":"Purroy","year":"2020","journal-title":"Redox Biol."},{"issue":"43","key":"10.1016\/j.abb.2020.108698_bib62","doi-asserted-by":"crossref","first-page":"42588","DOI":"10.1074\/jbc.M301872200","article-title":"Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease","volume":"278","author":"Pastore","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2011.11.003","article-title":"Changes in mitochondrial glutathione levels and protein thiol oxidation in \u0394yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia","volume":"1822","author":"Bulteau","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.abb.2020.108698_bib64","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phrs.2015.05.015","article-title":"Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia","volume":"99","author":"Abeti","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib65","doi-asserted-by":"crossref","first-page":"e2237","DOI":"10.1038\/cddis.2016.111","article-title":"Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia","volume":"7","author":"Abeti","year":"2016","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.abb.2020.108698_bib66","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/mds.22038","article-title":"Urinary isoprostanes in Friedreich ataxia: lack of correlation with disease features","volume":"23","author":"Myers","year":"2008","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.abb.2020.108698_bib67","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004253","article-title":"Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia","volume":"4","author":"Paupe","year":"2009","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12311-008-0087-z","article-title":"PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy","volume":"8","author":"Marmolino","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.abb.2020.108698_bib70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncel.2018.00188","article-title":"Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich's ataxia models","volume":"12","author":"Abeti","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia","volume":"6","author":"Lynch","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.abb.2020.108698_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2017.07.019","article-title":"Mitochondrial fusion, fission, and mitochondrial toxicity","volume":"391","author":"Meyer","year":"2017","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.abb.2020.108698_bib73","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1083\/jcb.201612106","article-title":"Mitochondrial fission facilitates the selective mitophagy of protein aggregates","volume":"216","author":"Burman","year":"2017","journal-title":"J.\u00a0Cell Biol."},{"issue":"15","key":"10.1016\/j.abb.2020.108698_bib74","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1074\/jbc.M607279200","article-title":"Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission","volume":"282","author":"Taguchi","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"7","key":"10.1016\/j.abb.2020.108698_bib75","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"issue":"7","key":"10.1016\/j.abb.2020.108698_bib77","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/embor.2009.86","article-title":"MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission","volume":"10","author":"Braschi","year":"2009","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00018-017-2603-0","article-title":"The ever-growing complexity of the mitochondrial fission machinery","volume":"75","author":"Pagliuso","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib79","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2014.09.144","article-title":"Cdk1, PKC\u03b4 and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death","volume":"453","author":"Zaja","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.abb.2020.108698_bib80","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1042\/CS20160030","article-title":"The role of Drp1 adaptor proteins MiD49 and MiD51 in mitochondrial fission: implications for human disease","volume":"130","author":"Atkins","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6054","key":"10.1016\/j.abb.2020.108698_bib81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1207385","article-title":"ER tubules mark sites of mitochondrial division","volume":"334","author":"Friedman","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.abb.2020.108698_bib82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2015.07.010","article-title":"Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction","volume":"86","author":"Li","year":"2015","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib83","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41419-017-0023-6","article-title":"Mitofusin 2: from functions to disease","volume":"9","author":"Filadi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tcb.2017.08.011","article-title":"Phosphatidic acid and cardiolipin coordinate mitochondrial dynamics","volume":"28","author":"Kameoka","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"12","key":"10.1016\/j.abb.2020.108698_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/antiox7120186","article-title":"Mitochondrial membrane dynamics-functional positioning of OPA1","volume":"7","author":"Lee","year":"2018","journal-title":"Antioxidants"},{"issue":"17","key":"10.1016\/j.abb.2020.108698_bib86","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1074\/jbc.M116.762567","article-title":"The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure","volume":"292","author":"Lee","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010144","article-title":"Drp1-Dependent mitochondrial fission plays critical roles in physiological and pathological progresses in mammals","volume":"18","author":"Hu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcb.2012.10.006","article-title":"Mitochondrial dynamics in neurodegeneration","volume":"23","author":"Itoh","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.abb.2020.108698_bib89","doi-asserted-by":"crossref","first-page":"e1663","DOI":"10.1038\/cddis.2014.595","article-title":"Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation","volume":"6","author":"Touvier","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.abb.2020.108698_bib90","doi-asserted-by":"crossref","first-page":"729290","DOI":"10.1155\/2012\/729290","article-title":"Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases","volume":"2012","author":"Corrado","year":"2012","journal-title":"Int. J. Cell Biol."},{"issue":"6","key":"10.1016\/j.abb.2020.108698_bib91","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.1810932116","article-title":"Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy","volume":"116","author":"Bernard-Marissal","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.25100\/cm.v46i4.1899","article-title":"Charcot Marie Tooth disease (CMT4A) due to GDAP1 mutation: report of a Colombian family","volume":"46","author":"Martin","year":"2015","journal-title":"Colomb. M\u00e9d."},{"issue":"21","key":"10.1016\/j.abb.2020.108698_bib93","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1093\/hmg\/ddx299","article-title":"Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model","volume":"26","author":"Wang","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5607\/en.2013.22.3.149","article-title":"Physiological and pathological significance of dynamin-related protein 1 (drp1)-dependent mitochondrial fission in the nervous system","volume":"22","author":"Cho","year":"2013","journal-title":"Exp. Neurobiol."},{"issue":"9","key":"10.1016\/j.abb.2020.108698_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090961","article-title":"Dynamics of dynamin-related protein 1 in Alzheimer's disease and other neurodegenerative diseases","volume":"8","author":"Oliver","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5607\/en.2018.27.3.171","article-title":"LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation","volume":"27","author":"Ho","year":"2018","journal-title":"Exp. Neurobiol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib97","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12035-014-8893-4","article-title":"The impact of mitochondrial fusion and fission modulation in sporadic Parkinson's disease","volume":"52","author":"Santos","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib98","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","article-title":"Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization","volume":"14","author":"Cassidy-Stone","year":"2008","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib99","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2008.02.005","article-title":"A\u00a0chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis","volume":"29","author":"Tanaka","year":"2008","journal-title":"Mol. Cell"},{"issue":"20","key":"10.1016\/j.abb.2020.108698_bib100","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1523\/JNEUROSCI.2385-16.2017","article-title":"Inhibition of Drp1 ameliorates synaptic depression, A\u03b2 deposition, and cognitive impairment in an Alzheimer's disease model","volume":"37","author":"Baek","year":"2017","journal-title":"J.\u00a0Neurosci."},{"issue":"25","key":"10.1016\/j.abb.2020.108698_bib101","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1093\/hmg\/ddv429","article-title":"Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease","volume":"24","author":"Manczak","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 3","key":"10.1016\/j.abb.2020.108698_bib102","first-page":"789","article-title":"A\u00a0novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity","volume":"126","author":"Qi","year":"2013","journal-title":"J.\u00a0Cell Sci."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib103","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.abb.2020.108698_bib104","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.abb.2020.108698_bib105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.expneurol.2017.02.015","article-title":"Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis","volume":"292","author":"Luo","year":"2017","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib106","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"issue":"7329","key":"10.1016\/j.abb.2020.108698_bib108","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A\u00a0role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.abb.2020.108698_bib109","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib111","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in\u00a0vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10753-017-0667-5","article-title":"NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model","volume":"41","author":"Gugliandolo","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.abb.2020.108698_bib113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib114","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"Suppl 1","key":"10.1016\/j.abb.2020.108698_bib115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.13217","article-title":"The pathogenic role of the inflammasome in neurodegenerative diseases","volume":"136","author":"Freeman","year":"2016","journal-title":"J.\u00a0Neurochem."},{"issue":"465","key":"10.1016\/j.abb.2020.108698_bib116","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.abb.2020.108698_bib117","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib118","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer's disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.abb.2020.108698_bib119","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.abb.2020.108698_bib120","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.abb.2020.108698_bib121","article-title":"Ferroptosis in low-grade glioma: a new marker for diagnosis and prognosis","volume":"26","author":"Liu","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"5","key":"10.1016\/j.abb.2020.108698_bib122","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.abb.2020.108698_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/antiox6030062","article-title":"Cysteine, glutathione, and thiol redox balance in astrocytes","volume":"6","author":"McBean","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.abb.2020.108698_bib124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","article-title":"Ferroptosis and cell death mechanisms in Parkinson's disease","volume":"104","author":"Guiney","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.abb.2020.108698_bib125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2013.09.019","article-title":"Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin","volume":"62","author":"Rhodes","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.abb.2020.108698_bib126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.118.252759","article-title":"Ferroptosis as a novel therapeutic target for Friedreich's ataxia","volume":"369","author":"Cotticelli","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"11\u201312","key":"10.1016\/j.abb.2020.108698_bib127","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.abb.2020.108698_bib128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC","volume":"94","author":"Do Van","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"34","key":"10.1016\/j.abb.2020.108698_bib129","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.abb.2020.108698_bib130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.dnarep.2018.08.022","article-title":"The comings and goings of PARP-1 in response to DNA damage","volume":"71","author":"Pascal","year":"2018","journal-title":"DNA Repair"},{"issue":"12","key":"10.1016\/j.abb.2020.108698_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121625","article-title":"The enigmatic function of PARP1: from PARylation activity to PAR readers","volume":"8","author":"Kamaletdinova","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.abb.2020.108698_bib132","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-pharmtox-010716-105001","article-title":"Mitochondrial mechanisms of neuronal cell death: potential therapeutics","volume":"57","author":"Dawson","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.abb.2020.108698_bib133","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/3297","article-title":"Parthanatos, a messenger of death","volume":"14","author":"David","year":"2009","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"8","key":"10.1016\/j.abb.2020.108698_bib134","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities","volume":"171","author":"Fatokun","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2020.108698_bib135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.expneurol.2009.03.020","article-title":"Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos","volume":"218","author":"Wang","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.abb.2020.108698_bib136","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2020.09.049","article-title":"Parthanatos in the pathogenesis of nervous system diseases","volume":"449","author":"Wang","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.abb.2020.108698_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.12.009","article-title":"Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases","volume":"353","author":"Park","year":"2020","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"6414","key":"10.1016\/j.abb.2020.108698_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson's disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.abb.2020.108698_bib139","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5483\/BMBRep.2014.47.8.119","article-title":"Poly (ADP-ribose) in the pathogenesis of Parkinson's disease","volume":"47","author":"Lee","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.abb.2020.108698_bib140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnagi.2020.00255","article-title":"Nicotinamide, a poly [ADP-Ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer's disease","volume":"12","author":"Salech","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.abb.2020.108698_bib141","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41514-018-0029-z","article-title":"CA1","volume":"4","author":"Johnson","year":"2018","journal-title":"NPJ Aging Mech. Dis."},{"key":"10.1016\/j.abb.2020.108698_bib142","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuroscience.2019.09.037","article-title":"Nicotinamide mononucleotide and melatonin alleviate aging-induced cognitive impairment via modulation of mitochondrial function and apoptosis in the prefrontal cortex and Hippocampus","volume":"423","author":"Hosseini","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.abb.2020.108698_bib143","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","article-title":"NAD","volume":"24","author":"Fang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.abb.2020.108698_bib144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12883-015-0272-x","article-title":"Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model","volume":"15","author":"Long","year":"2015","journal-title":"BMC Neurol."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120307074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120307074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:18:29Z","timestamp":1757744309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986120307074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":144,"alternative-id":["S0003986120307074"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2020.108698","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction in the development and progression of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2020.108698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108698"}}